News & Media
Purdue is at the forefront of medical advances and provides timely news updates about its family of products, resources, and events.
Purdue Pharma L.P.
Contact Us | Share
Recent News
Welcome to the Purdue Newsroom
In this section you will find recent news and events pertaining to Purdue, products, and programs.
Purdue Pharma L.P. To Present Data Regarding Long-Term Opioid Therapy At American Pain Society Annual Meeting
5/9/2013
Purdue Pharma L.P. Announces Resolution of OxyContin® (oxycodone HCl controlled-release) Tablets CII Patent Lawsuit with Actavis, Inc.
4/26/2013
Purdue Pharma L.P. Statement on FDA Approval of New Label for Reformulated OxyContin® (oxycodone HCL controlled-release) Tablets CII and FDA Decision Regarding Withdrawal of Original Formulation Due to Safety
4/16/2013
Want to go on a Shopping Spree?
4/12/2013
ElMindA and Purdue Pharma L.P. Enter Research Agreement to Develop Novel Diagnostics to Improve Pain Management
1/29/2013
Four Cities Win Grants For Outstanding Prescription Drug Abuse Prevention Initiatives
1/21/2013
National Community Pharmacists Association and Purdue Pharma Urge Americans to Safeguard Rx Medicines This Holiday Season
12/5/2012
NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to support State Prescription Drug Monitoring Programs
10/23/2012
Albuquerque Mayor Richard Berry Launches Public Education Campaign to Combat Prescription Medication Abuse Through Safe Storage and Disposal
7/26/2012
Purdue Pharma L.P. Comments on FDA Announcement On REMS For Extended-Release And Long-Acting Opioid Analgesics
7/9/2012
Partnership Aims to Prevent Students from Misusing Prescription Drugs
6/28/2012
Purdue Pharma L.P. to Present Data on Physician Understanding of the Risk Evaluation and Mitigation Strategy (REMS) For Butrans® (buprenorphine) Transdermal System CIII Data at International Society of Pharmacoeconomics and Outcomes Research Annual Meeting
6/4/2012
Purdue Pharma L.P. to Present Analysis of Butrans® (buprenorphine) Transdermal System CIII Clinical Data at American Pain Society Annual Meeting
5/18/2012
New Educational Resource Helps Healthcare Professionals Recognize, Address Substance Abuse in Clinical Practice Settings
4/30/2012
Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV Are Now Available for Insomnia Characterized by Middle-of-the-Night Awakenings Followed by Difficulty Returning to Sleep
4/10/2012
